Status:
UNKNOWN
Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism
Lead Sponsor:
Medical University of Vienna
Conditions:
Recurrent Venous Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Venous thromboembolism (VTE) is a common disease with an incidence of 1-2/1000 persons per year. VTE is a chronic disease with a considerable risk of recurrence. Patients with unprovoked VTE, i.e. VTE...
Eligibility Criteria
Inclusion
- Symptomatic uni- or bilateral proximal or distal deep vein thrombosis of the leg and/or symptomatic pulmonary embolism provoked by a temporary risk factor
- Scheduled to be treated with anticoagulants for at least 3 months
Exclusion
- Need for long-term anticoagulation
- Poor patient compliance
- No consent to participate
- VTE during pregnancy
Key Trial Info
Start Date :
September 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04124159
Start Date
September 15 2019
End Date
December 1 2023
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090